BridgeMD
New treatment option for Vitiligo Vulgaris
Official title PALLAS Laser for Skin Diseases
ClinicalTrials.gov ID: NCT07250997
What this study is testing
- What it's testing
- The primary objective of this study is to get clinical experiences with the PALLAS laser in the treatment of skin conditions that respond well to UV light (vitiligo, psoriasis, alopecia areata, atopic dermatitis). The secondary objective is to assess how user-friendly is the Pallas laser in the treatment of skin diseases.
- Time commitment: about 3 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- The subject understands the information provided, gives informed consent to participate in the study and is deemed by the investigator to be able to...
- a skin condition that is expected to respond well to targeted UVB treatment,
- a signed consent form.
You likely can't join if
- Patient under 18 years of age,
- pregnancy
- epilepsy,
- fever, infectious diseases,
- the patient is within one month or currently enrolled in another clinical trial.
The study team makes the final eligibility decision.
Where it's taking place
- Szeged, Csongrád-Csanád Vármegye, Hungary
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Szeged, Csongrád-Csanád Vármegye, Hungary. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.